Neuren Pharmaceuticals | NEU - Ordinary Share Capital


Neuren Pharmaceuticals reported AUD126.64M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Clinuvel Pharmaceuticals AUD 50.2M 77.11K Dec/2025
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Genetic Signatures AUD 227.14M 0 Dec/2025
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Organon & Co USD 262.61M 40K Jun/2026
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Telix Pharmaceuticals AUD 339.78M 1.01M Jun/2026
Viatris USD 1.16B 9.19M Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026